BioSpace News Archive

Cognition Therapeutics, Inc. (NASDAQ: CGTX) announced that a review article titled, “Sigma-2 Receptors – From Basic Biology to Therapeutic Target: A Focus on Age-Related Degenerative Diseases” ( doi.org/10.3390/ijms24076251 ) was published online in the International Journal of Molecular Sciences.

Theratechnologies Inc. today reported business highlights and financial results for the first quarter of fiscal year 2023 ended February 28, 2023 (Q1 2023). All figures are in US dollars unless otherwise stated.

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it will host a Research & Development Day on June 1, 2023, beginning at 9 a.m. ET in New York City.

Myriad Genetics, Inc. announced the planned launch of a new hereditary cancer assessment program that combines diagnostic imaging, genetic risk assessment utilizing MyRisk® with RiskScore® and patient education.

PDS Biotechnology Corporation announced it will host a Key Opinion Leader (KOL) Roundtable on Interleukin-12 (IL-12) for analysts, investors and the scientific community from 8:00 to 9:00 AM, ET on April 21, 2023.

Freeline Therapeutics Holdings plc announced that its Chief Executive Officer Michael Parini will present at the 22nd Annual Needham Virtual Healthcare Conference being held on April 17-20, 2023.

Cogent Biosciences, Inc. today announced its participation in the following upcoming virtual investor conferences.

Cybrexa Therapeutics, a clinical-stage oncology biotechnology company developing a novel class of tumor-targeting peptide drug conjugate therapeutics, announced the appointment of Jaya Gautam, Ph.D., as Senior Vice President, Technical Operations.

Vaccinex, Inc. today announced a new publication in the March 30, 2022 issue of Nature Communications describing a novel way that the ActivMAb® platform can be used for functional studies and drug discovery of the “hard to drug” class of membrane-associated G protein-coupled receptors (GPCRs) and ion channels.

Day One Biopharmaceuticals announced an upcoming poster presentation at the 19th European Association of Dermato-Oncology Congress being held from April 20-22, 2023 in Rome, Italy.